References: Rotarix™ significantly reduced severe rotavirus gastroenteritis in African babies during their first year of life

Views

CrossRef citations to date

Altmetric

References

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. The Journal of infectious diseases. 2005 Sep 1;192 Suppl 1:S160–6.
PubMed Web of Science ®Google Scholar
WHO. Rotavirus deaths under 5 years of age per 100,000 population under five (and number of deaths) by country http://www.who.int/immunization_monitoring/burden/rotavirus_deaths_2004_chart_b.jpg. Accessed August 2009, 2004.
Google Scholar
RotarixTM Liquid oral vaccine Package Insert 2009.
Google Scholar
Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007 Nov 24;370(9601):1757–63.
PubMed Web of Science ®Google Scholar
Parashar UD, Bresee JS, Gentsch JR, Glass RI. Rotavirus. Emerg Infect Dis. 1998 Oct-Dec;4(4):561–70.
PubMed Web of Science ®Google Scholar
Bresee JS, Hummelman E, Nelson EA, Glass RI. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. The Journal of infectious diseases. 2005 Sep 1;192 Suppl 1:S1–5.
PubMed Web of Science ®Google Scholar
Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003 May;9(5):565–72.
PubMed Web of Science ®Google Scholar